Nykredit A/S’s Gilead Sciences GILD Stock Holding History

Nykredit A/S’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$177M	Buy	+1,402,025	New	+$185M	0.56%	41

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nykredit A/S's GILD Position: Q2 2026 in Review

Nykredit A/S opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,402,025 shares worth $177M. The stake represents 0.56% of the portfolio and ranks #41 among its holdings.

1,880 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Nykredit A/S held 1,402,025 shares of Gilead Sciences worth $177M as of Q2 2026.
Gilead Sciences was a new Nykredit A/S position in Q2 2026.
Gilead Sciences made up 0.56% of Nykredit A/S's portfolio in Q2 2026, its #41 holding.
1,880 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.